2023
Salicylanilides and Their Anticancer Properties
KAUEROVÁ, Tereza, Maria-Jesus PEREZ-PEREZ a Peter KOLLÁRZákladní údaje
Originální název
Salicylanilides and Their Anticancer Properties
Autoři
KAUEROVÁ, Tereza (203 Česká republika, domácí), Maria-Jesus PEREZ-PEREZ a Peter KOLLÁR (203 Česká republika, garant, domácí)
Vydání
International Journal of Molecular Sciences, Basel, Multidisciplinary Digital Publishing Institute, 2023, 1422-0067
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30104 Pharmacology and pharmacy
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 5.600 v roce 2022
Kód RIV
RIV/00216224:14160/23:00132228
Organizační jednotka
Farmaceutická fakulta
UT WoS
000914982800001
Klíčová slova anglicky
salicylanilides; anticancer properties; mitochondrial uncoupling; TK EGFR; STAT3; drug repurposing; niclosamide
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 5. 4. 2024 07:35, Mgr. Daniela Černá
Anotace
V originále
Salicylanilides are pharmacologically active compounds with a wide spectrum of biological effects. Halogenated salicylanilides, which have been used for decades in human and veterinary medicine as anthelmintics, have recently emerged as candidates for drug repurposing in oncology. The most prominent example of salicylanilide anthelmintic, that is intensively studied for its potential anticancer properties, is niclosamide. Nevertheless, recent studies have discovered extensive anticancer potential in a number of other salicylanilides. This potential of their anticancer action is mediated most likely by diverse mechanisms of action such as uncoupling of oxidative phosphorylation, inhibition of protein tyrosine kinase epidermal growth factor receptor, modulation of different signaling pathways as Wnt/beta-catenin, mTORC1, STAT3, NF-kappa B and Notch signaling pathways or induction of B-Raf V600E inhibition. Here we provide a comprehensive overview of the current knowledge about the proposed mechanisms of action of anticancer activity of salicylanilides based on preclinical in vitro and in vivo studies, or structural requirements for such an activity.